TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
PolyPeptide Laboratories (Sweden) AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,066,269
|
901,324
|
977,189 |
Financial expenses |
23,475
|
3,679
|
3,279 |
Earnings before taxes |
193,891
|
299,633
|
407,905 |
EBITDA |
258,777
|
278,592
|
418,884 |
Total assets |
1,991,348
|
1,517,046
|
1,435,808 |
Current assets |
1,325,208
|
895,312
|
984,012 |
Current liabilities |
417,197
|
314,789
|
338,711 |
Equity capital |
1,119,402
|
1,046,481
|
975,128 |
- share capital |
11,500
![]() |
11,500
![]() |
11,500 |
Employees (average) |
312
|
325
|
297 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
56.2%
|
69.0%
|
67.9% |
Turnover per employee |
3,418
|
2,773
|
3,290 |
Profit as a percentage of turnover |
18.2%
|
33.2%
|
41.7% |
Return on assets (ROA) |
10.9%
|
20.0%
|
28.6% |
Current ratio |
317.6%
|
284.4%
|
290.5% |
Return on equity (ROE) |
17.3%
|
28.6%
|
41.8% |
Change turnover |
164,945
|
-75,865
|
245,159 |
Change turnover % |
18%
|
-8%
|
33% |
Chg. No. of employees |
-13
|
28
|
31 |
Chg. No. of employees % |
-4%
|
9%
|
12% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.